HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H De Smedt Selected Research

Inositol 1,4,5-Trisphosphate

5/2013IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2.
8/2002IP(3)-mediated Ca(2+) signals in human neuroblastoma SH-SY5Y cells with exogenous overexpression of type 3 IP(3) receptor.
11/2001Calcium puffs are generic InsP(3)-activated elementary calcium signals and are downregulated by prolonged hormonal stimulation to inhibit cellular calcium responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H De Smedt Research Topics

Disease

3Neuroblastoma
08/2002 - 06/2000
2B-Cell Lymphoma (Lymphoma, B Cell)
05/2013 - 02/2012
2Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic)
07/2000 - 01/2000
2Alzheimer Disease (Alzheimer's Disease)
07/2000 - 01/2000
2Central Core Myopathy (Central Core Disease)
07/2000 - 01/2000
2Brody myopathy
07/2000 - 01/2000
2Malignant Hyperthermia
07/2000 - 01/2000
2Spinocerebellar Ataxias (Spinocerebellar Ataxia)
07/2000 - 01/2000
1Leukopenia
02/2016
1Polycythemia (Erythrocytosis)
02/2016
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2013
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2013
1Neoplasms (Cancer)
05/2013
1Nasal Obstruction
08/2006
1Benign Familial Pemphigus (Hailey Hailey Disease)
08/2003
1Hyperglycemia
05/2001
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
07/2000
1Episodic Ataxia
07/2000
1Cardiomegaly (Heart Hypertrophy)
07/2000
1Migraine Disorders (Migraine)
07/2000
1Major Affective Disorder 2
07/2000
1Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome)
07/2000
1Epilepsy (Aura)
07/2000
1Diabetes Mellitus
07/2000
1Nervous System Diseases (Neurological Disorders)
01/2000
1Type 2 Episodic Ataxia
01/2000
1Bipolar Disorder (Manic Depressive Psychosis)
01/2000
1Migraine with Aura (Familial Hemiplegic Migraine)
01/2000
1Oculocerebrorenal Syndrome (Lowe Syndrome)
01/2000

Drug/Important Bio-Agent (IBA)

3Inositol 1,4,5-TrisphosphateIBA
05/2013 - 11/2001
2Proteins (Proteins, Gene)FDA Link
02/2016 - 07/2000
2Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA
05/2013 - 02/2012
2Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
07/2000 - 01/2000
1Peptides (Polypeptides)IBA
05/2013
1Inosine Diphosphate (IDP)IBA
05/2013
1Histamine Antagonists (Antihistamines)IBA
08/2006
1levocetirizineFDA LinkGeneric
08/2006
1NeuropeptidesIBA
08/2006
1AllergensIBA
08/2006
1Adenosine Triphosphatases (ATPase)IBA
08/2003
1Complementary DNA (cDNA)IBA
08/2002
1Protein Kinase CIBA
05/2001
1Retinal Pigments (Pigments, Visual)IBA
05/2001
1Connexin 43 (Connexin43)IBA
05/2001
1AntibodiesIBA
07/2000
1L-Type Calcium Channels (Dihydropyridine Receptor)IBA
07/2000
1Inositol (Myoinositol)IBA
07/2000
1Fluo-3IBA
06/2000
1DigitoninIBA
06/2000
1Indicators and Reagents (Reagents)IBA
06/2000
1Glutamic Acid (Glutamate)FDA Link
01/2000